From Structural Modification to Diverse Pharmacological Activities: Recent Advances and Future Perspectives of Bile Acids.

Authors

Hongxia Zhu, Heming Chen, Qi Gong, Zhe-Sheng Chen, Chuan Zhang, Jinyi Xu, Tingfang Wang

Published in

Medicinal research reviews. Oct 18, 2026. Epub Oct 18, 2026.

Abstract

Bile acids (BAs) are amphiphilic steroid acids that exert a broad range of physiological effects-including the regulation of metabolism, immune responses, and inflammatory processes-through activation of specific receptors such as the farnesoid X receptor (FXR) and the G protein-coupled bile acid receptor 1 (TGR5). The gut microbiota plays a critical role in BA metabolism, and alterations in the BA pool have been closely linked to various metabolic disorders, including nonalcoholic fatty liver disease and type 2 diabetes. Consequently, targeting BA signaling pathways offers a novel mechanistic perspective for the prevention and treatment of these metabolic and inflammatory diseases. With growing insight into the biological functions of BAs, the development of BA-based therapeutics and their structural derivatives is emerging as a promising strategy for the management of metabolic diseases.

PMID:
42893506
Bibliographic data and abstract were imported from PubMed on 19 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.